Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossCommercial · Coverage · Pharmacy · PA · Hematology, Neurology, Transplant Surgery +2 moreMedium impact

08.01.92, Elivaldogene Autotemcel [eli-cel (Skysona®)]

Act
immediately
Effective date
Not stated in the notice
Identified
Oct 1, 2026

Summary

Independence Blue Cross reissued Policy 08.01.92 on September 30, 2026 (most recent revision) to reaffirm its continuing coverage position for elivaldogene autotemcel (Skysona®) for treating cerebral adrenoleukodystrophy (CALD) in eligible boys ages 4-17. This is a reissue with no substantive changes to coverage criteria, requiring documentation of genetic confirmation, elevated very-long-chain fatty acids, early active CALD markers, adequate organ function, and negative infectious disease screening. Billing teams must ensure claims use the correct HCPCS codes and include all required clinical documentation to support medical necessity.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

immediately · 10 steps
01Billing and prior authorization teams must maintain current procedures for elivaldogene autotemcel (Skysona®) claims under Policy 08.01.92.
02For all new requests.
03Verify patient meets ALL eligibility criteria (male, age 4-17, genetic ABCD1 confirmation, elevated VLCFAs, NFS ≤1, GdE+ on MRI, Loes score 0.5-9, no prior allo-HSCT).
04Require documentation of adequate hepatic, hematological, renal, and cardiac function per specified lab values.
05Confirm negative screening for HBV, HCV, HTLV 1/2, and HIV 1/2.
06Obtain attestation from hematologist, neurologist, or stem cell transplant specialist confirming no active infection, prior malignancy, familial cancer syndrome, and patient ineligibility for HSCT due to lack of 10/10 HLA-matched sibling donor.
07Bill using HCPCS codes C9399 or J3590 with ICD-10 diagnosis E71.520.
08Ensure all prior authorization requests include complete clinical documentation supporting all medical necessity criteria.
09Non-compliance will result in claim denials.
10Update prior authorization templates and internal guidelines to reflect current policy position if not already done.

Codes mentioned

C9399J3590E71.520

Original notice

08.01.92, Elivaldogene Autotemcel [eli-cel (Skysona®)]
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related changes

See all Independence Blue Cross changes →
MA08.172, Lifileucel (Amtagvi™)LowEffective Oct 21, 2024 · Pharmacy08.02.22, Lifileucel (Amtagvi™)LowEffective Oct 21, 2024 · PharmacyMA08.070h, Golimumab and Related Biosimilars for Intravenous InfusionMediumEffective Oct 19, 2026 · PharmacyMA08.117f, Isatuximab-irfc (Sarclisa®, Sarclisa Escena)MediumEffective Oct 19, 2026 · PharmacyBrowse every Independence Blue Cross change in the policy list

Related policy hubs

Independence Blue Cross policiesPA policy changesHematologyNeurologyTransplant SurgeryPediatricsPharmacyCode C9399Code J3590Code E71.520

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account